The fight against chronic diseases like heart disease and diabetes is fueling rapid growth in the Cardiometabolic Drugs Market. A new industry report reveals a market value of USD 50 billion in 2021, with projections of reaching a staggering USD 70 billion by 2032. This represents a steady Compound Annual Growth Rate (CAGR) of 4% …
Tag Archives: Cardiometabolic Drugs
Cardiometabolic Drugs Market Set to Reach $70 Billion by 2032 Driven by Growing Heart Disease and Diabetes
The Cardiometabolic Drugs Market is experiencing steady growth as the fight against heart disease and diabetes intensifies. A new industry report estimates the market reached a value of US$50 billion in 2021 and is projected to reach a staggering US$70 billion by 2032. This translates to a Compound Annual Growth Rate (CAGR) of 4% to …
Global Cardiometabolic Drugs Industry to Flourish with a 4-5% CAGR, Exceeding US$70 Billion by 2032 | FMI
The Global Cardiometabolic Drugs Industry is on the brink of a remarkable surge, projected to reach a substantial US$ 50 billion by 2021, and further skyrocketing to exceed US$ 70 billion by 2032, according to the latest market analysis. These insights, driven by a Compound Annual Growth Rate (CAGR) of 4% to 5% between 2022 and 2032, …
Global Cardiometabolic Drugs Industry Expected to Surpass US$ 70 Billion, at a CAGR of 4% to 5% between 2022 and 2032
The Global Cardiometabolic Drugs Industry is on the brink of a remarkable surge, projected to reach a substantial US$ 50 billion by 2021, and further skyrocketing to exceed US$ 70 billion by 2032, according to the latest market analysis. These insights, driven by a Compound Annual Growth Rate (CAGR) of 4% to 5% between 2022 …